Changjiang Securities(SZ:000783) Changjiang Securities·2025-09-11 14:45Core Insights - The Hong Kong stock market experienced a total trading volume of HKD 325.21 billion on September 11, 2025, with net inflows from southbound funds amounting to HKD 18.989 billion. The three major indices in Hong Kong showed a downward trend, reflecting overall market weakness [1][5]. - The AI computing sector saw a significant boost due to better-than-expected earnings from overseas AI giants, which provided positive guidance for future AI-related revenues. This led to a strong performance in related stocks, significantly driving the Wind Hong Kong Semiconductor Index to become the leading sector in the market [5]. - The automotive industry in China reported production and sales exceeding 20 million units from January to August 2025, with new energy vehicle production and sales growing over 36% year-on-year. This surge is expected to enhance demand for rare earth permanent magnets and other related materials, contributing to a strong performance in the Wind Hong Kong Nonferrous Metals Index [5]. Market Performance - On September 11, 2025, the Hang Seng Index fell by 0.43% to 26,086.32, the Hang Seng Tech Index decreased by 0.24% to 5,888.77, and the Hang Seng China Enterprises Index dropped by 0.73% to 9,260.25. In contrast, the Hang Seng High Dividend Yield Index rose by 0.27% [4][10]. - In the A-share market, the Shanghai Composite Index increased by 1.65%, the CSI 300 rose by 2.31%, and the Wind All A Index gained 2.26% [4][10]. Sector Analysis - Among the primary sectors in the Hong Kong stock market, Nonferrous Metals (+2.82%), Agriculture, Forestry, Animal Husbandry, and Fishery (+1.84%), and Machinery (+1.72%) led the gains, while Pharmaceuticals (-2.95%), Oil and Petrochemicals (-2.34%), and Steel (-2.23%) faced declines [4][10]. - Concept indices such as the Foxconn Index (+11.79%), Chip Replacement Index (+5.35%), and Unisplendour System Index (+5.12%) showed strong performance, while the CRO Index (-4.05%), Innovative Drug Index (-3.73%), and Antitumor Index (-3.52%) lagged behind [4][10].